147 related articles for article (PubMed ID: 38704498)
1. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
Vincent A; Krishnakumar S; Parameswaran S
Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
3. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
6. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma from human stem cell-derived retinal organoids.
Norrie JL; Nityanandam A; Lai K; Chen X; Wilson M; Stewart E; Griffiths L; Jin H; Wu G; Orr B; Tran Q; Allen S; Reilly C; Zhou X; Zhang J; Newman K; Johnson D; Brennan R; Dyer MA
Nat Commun; 2021 Jul; 12(1):4535. PubMed ID: 34315877
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
Agrawal T; Maddileti S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
[TBL] [Abstract][Full Text] [Related]
9.
Kanber D; Woestefeld J; Döpper H; Bozet M; Brenzel A; Altmüller J; Kilpert F; Lohmann D; Pommerenke C; Steenpass L
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565295
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Histochem Cell Biol; 2022 Aug; 158(2):181-192. PubMed ID: 35445864
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into RB1 mutation.
Yao Y; Gu X; Xu X; Ge S; Jia R
Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
[TBL] [Abstract][Full Text] [Related]
16. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
17. Reconstruct Human Retinoblastoma In Vitro.
Zhang X; Jin ZB
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36314812
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
19. Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs.
Xu J; Yu SJ; Sun S; Li YP; Zhang X; Jin K; Jin ZB
Glia; 2024 May; 72(5):872-884. PubMed ID: 38258347
[TBL] [Abstract][Full Text] [Related]
20. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF
Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
